Post-Finasteride Syndrome: Our Current Knowledge

    July 2020 in “ Vestnik urologii
    А А Галушкин, Д. Г. Лихих, М. И. Коган
    TLDR The cause of post-finasteride syndrome is unclear and needs more research.
    The document discussed post-finasteride syndrome (PFS), a condition that was reported to occur in some individuals after the use of finasteride, a medication commonly used to treat hair loss and benign prostatic hyperplasia. PFS was characterized by persistent sexual, neurological, and physical side effects that continued even after discontinuation of the drug. The article reviewed the current understanding of PFS, highlighting the need for further research to better understand its mechanisms and to develop effective treatment strategies. It emphasized that while the syndrome was recognized, the exact prevalence and pathophysiology remained unclear, necessitating more comprehensive studies to validate and explore these aspects.
    Discuss this study in the Community →

    Research cited in this study

    14 / 14 results

    Related Community Posts Join

    6 / 1000+ results

      community Don't give up on finasteride folks

      in Finasteride/Dutasteride  283 upvotes 2 months ago
      Finasteride may take over two years to show results and can cause side effects like sexual dysfunction and emotional changes. Alternatives such as dutasteride and minoxidil are discussed, with varying effectiveness and side effects.

      community risks with finasteride and dutasteride

      in Research/Science  138 upvotes 1 week ago
      Finasteride and dutasteride have potential risks, including post-finasteride syndrome, but are commonly used for hair loss. RU58841, minoxidil, and needling are suggested as alternatives, though all treatments carry risks.

      community Age 18 vs Age 25, the importance of starting early

      in Progress Pictures  886 upvotes 7 months ago
      An 18-year-old began using Finasteride and Topical Minoxidil for hair loss, later switching to Oral Minoxidil and Dutasteride by age 25. The conversation emphasizes early treatment, potential side effects, and differing opinions on medication effectiveness.

    Related Research

    1 / 1 results